Cholesterol drugs Zeta and Vytorin face class action suits
To update our article on Vytorin, Merck & Co. and Schering-Plough Corp and facing class action suits for Zetia and Vytorin in four different states.
The class members include patients and medical insurers who paid for the drug that apparently had no positive medical benefits.
The complaint says that the drug manufacturers placed profits over concern for its impact on the health of users.
The Zetia and Vytorin class action suits are seeking compensation for the cost of the prescription or the difference between the cost of their prescription and what the generic cholesterol drugs would have cost.
The attorneys at Saiontz, Kirk & Miles in Baltimore, Maryland are also analyzing the possibility for individual Vytorin lawsuits for users of the drugs who suffered a heart attack or stroke.
Since Vytorin does not give any medical benefit, even the smallest increase in the risk of a heart attack or stroke would be unacceptable.
Related posts:
Sphere: Related Content
Leave a Reply